Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Café Scientifique Program

Research Institute of the McGill University Health Centre

$3,000.00

When a pregnancy leads to a tumor: Gestational Trophoblastic Diseases

FY 2013-14

Summary
Pregnancy and the enlargement of one's family often lead to happiness and celebration. Unfortunately, not all pregnancies result in the term-birth of a healthy baby. Embryo loss occurs in half the pregnancies. Even scarier, 1/600 pregnancy results in a rare type of tumor that can potentially put the future mother's life at risk. Among the treatments for these tumors, one of them is as drastic as removing the woman's uterus. We propose to hold a Café Scientifique to discuss this group of tumors called: Gestational Trophoblastic Diseases (GTDs). We will begin by explaining what these tumors are and how they appear during or following a pregnancy. We will then go on to discuss subsequent pregnancies, the increasing risks of miscarriages related to GTDs and the possibility of infertility. As GTDs are rare and little information is accessible, our aim is to inform our audience members, answer their questions and hear their concerns on this subject.
Program
CIHR Café Scientifique Program
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
288184
Name
Slim Rima
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Clinical
Prcname2
CIHR Café Scientifique Program
Projecttitle
When a pregnancy leads to a tumor: Gestational Trophoblastic Diseases
Programtype2
Miscellaneous Programs
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$3,000
Cihrequipment2
$0
Programname2
CIHR Café Scientifique Program
Keyworddelim
Abnormal Pregnancies; Infertility; Miscarriage; Molar Pregnancies; Placenta; Stillbirth; Tumour; Women'S Health
Abstract
Pregnancy and the enlargement of one's family often lead to happiness and celebration. Unfortunately, not all pregnancies result in the term-birth of a healthy baby. Embryo loss occurs in half the pregnancies. Even scarier, 1/600 pregnancy results in a rare type of tumor that can potentially put the future mother's life at risk. Among the treatments for these tumors, one of them is as drastic as removing the woman's uterus. We propose to hold a Café Scientifique to discuss this group of tumors called: Gestational Trophoblastic Diseases (GTDs). We will begin by explaining what these tumors are and how they appear during or following a pregnancy. We will then go on to discuss subsequent pregnancies, the increasing risks of miscarriages related to GTDs and the possibility of infertility. As GTDs are rare and little information is accessible, our aim is to inform our audience members, answer their questions and hear their concerns on this subject.
Competitiondate
201305
Approvedterm2
1 yr 0 mth
Pinamesdelim
Slim, Rima
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $3,000~ $0~